The industry can breathe a sigh of relief: confidence in the US medtech market appeared to be recovering in Q4 2011 after fairly steep falls in Q2 and Q3. This seems to be happening in line with a tentatively optimistic outlook on the US economy: unemployment is declining, the housing market is looking healthier, and tax revenues are recovering.  But can this rising confidence be maintained throughout the rest of 2012.

It's worth noting that in both 2010 and 2011, job growth looked pretty positive in Q1 before fading out later in the year. And economic problems in Europe are far from over unemployment in Greece and Spain is sitting above 20% and we know how uncertainty in Europe can cause problems in the US. The fact that it's an election year also creates a bit of uncertainty with how the rest of the year will play out.

Nonetheless, the story is pretty positive overall, particularly confidence in the cardiovascular market outside of the US and Europe, which has reached a record high. The orthopedics market also showed an uptick in Q4 after dropping throughout 2011.

But we should definitely see how confidence turns out in Q1 and Q2 2012 before everyone gets too excited.

For more details on MRG's Q4 2011 MCI results, please take a look here.

What drives the therapy selection test market?

View Now